Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart Disease-Insights from ENGAGE AF-TIMI 48-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart Disease-Insights from ENGAGE AF-TIMI 48

Published:2017-08 Issue:8 Volume:40 Page:612-613
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Owens Ryan E.¹^ORCID,Kabra Rajesh²,Oliphant Carrie S.³

Affiliation:

1. Department of Pharmacy: Clinical and Administrative Sciences; University of Oklahoma College of Pharmacy; Oklahoma City Oklahoma

2. Division of Cardiology, Department of Internal Medicine; University of Tennessee Health Science Center; Memphis Tennessee

3. Department of Clinical Pharmacy, University of Tennessee College of Pharmacy; Methodist University Hospital; Memphis Tennessee

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference4 articles.

1. Owens RE Kabra R Oliphant CS Clin Cardiol

2. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

3. Outcomes of 2824 patients with valvular heart disease treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial;Renda;J Am Coll Cardiol,2016

4. Edoxaban for the prevention of thromboembolism in patients with bioprosthetic valves in ENGAGE AF-TIMI 48 [abstract 17513];Carnicelli;Circulation,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of edoxaban in clinical practice: Comparison of data from the Spanish population in the ETNA-AF-Europe registry;Future Cardiology;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP